National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

clopidogrel bisulfate
A thienopyridine with antiplatelet activity. Clopidogrel bisulfate irreversibly alters the platelet receptor for adenosine diphosphate (ADP), thereby blocking the binding of ADP to its receptor, inhibiting ADP-mediated activation of the glycoprotein complex GPIIb/IIIa, and inhibiting fibrinogen binding to platelets and platelet adhesion and aggregation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Plavix
Abbreviation:CLOBI



Previous:Clofarex, clofibrate, Clolar, Clomid, clomiphene citrate
Next:Cloretazine, clotrimazole, CMF regimen, CMV N495 peptide, CMV pp65 peptide

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov